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Objective: To present a case of sclerosing polycystic adenosis (SPA) of the parotid gland,
highlighting the probable etiology and the benign behavior of these cases.
Case report: A woman of 22 years old had a right parotid mass with a slowly progres-
sive  growth associated with a chronic infection due to Epstein–Barr virus. Initially, it was
asymptomatic and subsequently the patient developed light dysesthesias in the region. A
superﬁcial parotidectomy was done and the microscopic study informed SPA.
Conclusion: The SPA is similar to the ﬁbrocystic changes, sclerosing adenosis and adenoid
tumors of the mammary gland. The main location of the SPA is the parotid gland and it is
considered a disease due to a pseudotumoral inﬂammatory reaction with a possible associ-
ation with the Epstein–Barr virus. There is evidence that monoclonal cell populations exist.
The treatment consists in excision of the tumor with a superﬁcial parotidectomy, which has
demonstrated high cure rates.
©  2014 SECOM. Published by Elsevier España, S.L.U. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Adenosis  Poliquística  Esclerosante  de  la  Glándula  Parótida:  Un  tumor  raro
aparentemente  benigno
alabras clave:
denosis poliquística esclerosante
lándula parótida
r  e  s  u  m  e  n
Objetivo: Presentar un caso de adenosis poliquística esclerosante (APE) de la glándula
parótida, destacando la etiología probable y el comportamiento benigno de estos casos.
Caso  clínico: Mujer de 22 an˜os con una masa parotídea derecha de crecimiento lentamente
pstein–Barr virus
arotidectomía superﬁcial
progresivo asociada con una infección crónica por el virus de Epstein–Barr. Inicialmente,
era  asintomática y posteriormente desarrolló disestesias ligeras en la región. Se realiza una
parotidectomía superﬁcial y el resultado histopatológico es de APE.
Conclusión: La APE muestra cambios histopatológicos similares a los hallados en la enfer-
medad ﬁbroquística, adenosis esclerosante y los tumores adenoideos de la glándula
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mamaria. La ubicación salivar principal de la APE es la glándula parótida y se trata de
una  enfermedad causada por una reacción inﬂamatoria pseudotumoral con una posible
asociación con el virus de Epstein–Barr. Hay pruebas de que existen poblaciones celulares
monoclonales. El tratamiento de elección es quirúrgico, siendo la parotidectomía superﬁcial
la  técnica de elección al haber demostrado tasas de curación elevadas.
©  2014 SECOM. Publicado por Elsevier España, S.L.U. Este es un artículo Open Access
cia Cbajo la licen
Introduction
The parotid gland tumors are classiﬁed according to their
morphological and histological patterns. The most com-
mon  site of presentation of a salivary neoplasm is the
parotid gland. The 85% of these neoplasms are benign
tumors, being the pleomorphic adenoma the most frequent
type.1
Sclerosing polycystic adenosis (SPA) is a rare disease of the
salivary glands, ﬁrst described by Smith et al. at 1996.2 The
SPA is similar to the ﬁbrocystic changes, sclerosing adenosis
and adenoid tumors of the mammary  gland.3,4 The main loca-
tion of the SPA is the parotid gland, but there are reported
cases in the submandibular and accessory salivary glands
too2
Case  report
A woman  of 22 years old with no pathologic family history
has a negative IgM, but with a positive IgG Epstein–Barr serum
antibody test. The patient went to the ENT because of a right
parotid mass with a slowly progressive growth of 8 months.
Initially, it was asymptomatic and subsequently the patient
developed light dysesthesias in the region.
A physical examination was done. A hard, painless, non-
ﬂuctuating tumor of 2 cm × 2 cm of maximum diameter was
revealed, posterior to the right angle of the jaw, and with-
out trophic changes in the skin. In the T2 of the MRI it is
conﬁrmed a 2 cm × 1.8 cm in diameter mass in the tail of
the right parotid with hyperintense areas inside the gland,
but without spreading to adjacent structures (Fig. 1A and
B). Fine needle aspiration cytology was performed to orien-
tate the diagnosis, having a histopathologic result of chronic
sialadenitis.
The provisional probable diagnosis was a parotid tumor
with a clinical and radiological benign behavior, likely a
pleomorphic adenoma. Therefore a preauricular parotidec-
tomy was done by cervical incision, removing the supra-facial
portion of the right parotid gland. The microscopic study
informed glandular parenchyma in continuity with a dense-
hyaline connective tissue with undeﬁned borders that forms a
sclerosing-hyaline stroma mass with inﬂammatory cells and
interposed myoepithelial elements. No nuclear atypia of the
ductal and squamous epithelium was revealed (Fig. 2A and B).
This is suggestive of sclerosing polycystic adenosis (SPA) of the
parotid gland. At one year of follow-up, the patient is asymp-
tomatic, with a favorable clinical outcome and without tumor
relapse.C BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Discussion
There have been about 51 cases of sclerosing polycyst adenosis
(SPA) in the salivary glands published. All cases of SPA have
been unilateral like this case report.5
These tumors are diagnosed at a mean age of 40 years and
the mean tumor size is in the range of 0.3–6 cm.  The clinical
picture is nonspeciﬁc, presenting in most cases as a progres-
sively growing intraparotid asymptomatic mass, although in
some cases the tumor has been associated with pain and/or
paresthesias in the region.2,6
These tumors are usually single, well-deﬁned and partially
encapsulated. There are few cases of SPA that have become
multinodular. Moreover, there have been cases associated
with mandibular pleomorphic adenomas, parotid oncocy-
tomas or Whartin tumors.2,6
The pathogenesis of SPA is unknown, although there has
been a possible association with the Epstein–Barr virus7 and in
this particular case there is a history of chronic infection with
this virus. Furthermore, there is evidence that monoclonal cell
populations exist in some cases of SPA, however the meaning
of this clonality is still uncertain. There is no gender predom-
inance, although it is considered a slight predilection toward
females.7
SPA is considered a disease due to a pseudotumoral inﬂam-
matory reaction. However because of the risk of recurrence
and the presence of cell clonality it has been considered that
it might have a tumoral origin.2
There are few descriptions of radiology because of the rarity
of the tumor, but in the majority of cases it has been described
a parotid mass with small cystic areas which are hyperintense
on contrast-enhanced T2 MRI. In the ultrasound, it is described
as a hypoechoic lesion, with well demarcated micro-cystic
areas.7
Microscopically the SPA consists of lobes circum-
scribed by hyaline connective tissue. Moreover, within
the ﬁbrous tissue there is hyperplastic ductal and aci-
nar epithelium with no differentiation.7,8 There has not
been observed carcinomatous degeneration so far. Speciﬁc
immunohistochemistry antibodies as anti-smooth muscle
actin, can conﬁrm the integrity of the myoepithelial cells
layer in benign tumors, which is lost in carcinomatous
lesions.2
Progesterone receptors have been demonstrated in 80% of
epithelial cells and in 20% of cases there have been estrogen
receptors in the dysplasic spotlights of ductal cells. Cytokera-
tin has been observed in the tubuloacinar elements and S-100,
smooth muscle actin, and calponin stain is present in the
myoepithelial cells.5
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Figure 1 – A mass of 2 cm × 2 cm of maximum diameter was revealed, posterior to the right angle of the jaw (A). Axial T2
MRI  image of the neck, it is conﬁrmed a 2 cm × 1.8 cm in diameter tumor in the tail of the right parotid, with hyperintense
areas inside the gland but without evidence of extension to adjacent structures (B).
Figure 2 – The microscopic study reveal a parotid gland tissue with periductal inﬂammation and ﬁbrosis with intraluminal
cellular debris and polymorphic nuclear cells. This glandular parenchyma appears in continuity with a dense-hyaline
connective tissue with undeﬁned borders that forms a sclerosing-hyaline stroma mass with inﬂammatory cells and
interposed myoepithelial elements. (H&E; original magniﬁcation, 10×:  A). A microscopic image with more  detail reveals
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rhere is no presence of nuclear atypia of the ductal and squa
There are few diagnosed cases by ﬁne needle cytology, in
hich cases there are found syncytial cells of epithelial ducts
ith apocrine changes.3,8 The differential diagnosis should
nclude acinar cell carcinoma, sclerosing sialadenitis, sali-
ary ductal carcinoma and adenocarcinoma.6 Mild dysplasia
s reported in up to 30% of the cases and in about 10% there
as been found a low grade in situ carcinoma.1
The treatment in most cases consists of excision of the
umor with a superﬁcial parotidectomy with adequate surgi-
al margins and facial nerve sparing, which has demonstrated
 prolonged survival.2,4 Recurrences are rare and usually due
o incomplete surgical excision or occult multifocal disease
ather than a real recurrence.7 Local recurrence appeared
etween 19 and 30% of all cases.4,5 There are no documented
etastases or associated mortality due to the SPA.8
thical  disclosuresrotection of human and animal subjects. The authors
eclare that no experiments were performed on humans or
nimals for this study.
1
2s epithelium (H&E; original magniﬁcation, 100×: B).
Conﬁdentiality of data. The authors declare that they have fol-
lowed the protocols of their work center on the publication of
patient data.
Right to privacy and informed consent. The authors have
obtained the written informed consent of the patients or sub-
jects mentioned in the article. The corresponding author is in
possession of this document.
Conﬂict  of  interest
The authors declare no conﬂict of interest.
 e  f  e  r  e  n  c  e  s
. Bharadwaj G, Nawroz I, O’Regan B. Sclerosing polycyst
adenosis of the parotid gland. Br J Oral Maxillofac Surg.
2007;45:74–6.
. Perottino F, Barnoud R, Ambrun A, Poupart M,  Pignat JC, Merrot
O.  Sclerosing polycystic adenosis of parotud gland: diagnosis
 i l o f
3
4
5
6
7
8242  r e v e s p c i r o r a l m a x
and management. Eur Ann Otorhinolaryngol Head Neck Dis.
2010;127:20–2.
. Gupta R, Jain R, Singh S. Sclerosis polycyst adenosis of parotid
gland: a cytological diagnosis dilemma. Cytopathology.
2009;20:130–2.
. Gnepp DR, Wang LJ, Brandwein-Gensler M, Slootweg Pieter, Gill
Melissa, Hillie J. Sclerosing polycystic adenosis of salivary
gland: a report of 16 cases. Am J Surg Pathol. 2006;30:
154–64.
. Kim BC, Yang DH, Kim J, Samayoa SR, Na HY, Choi EJ, et al.
Sclerosis polycyst adenosis of the parotid gland. J Craniofac
Surg. 2012;23:452. a c . 2 0 1 5;3 7(4):239–242
. Peterson F, Tan PH, Hwang JS. Sclerosing polycystic adenosis of
the parotid gland: report of a bifocal, paucicyst variant with
ductal carcinoma in situ and pronounced stromal distortion
mimicking invasive carcinoma. Head Neck Pathol.
2011;5:188–92.
. Eliot CA, Smith AB, Foss RD. Sclerosing polycystic adenosis.
Head Neck Pathol. 2012;6:247–9.
. Fulcinitti F, Losito NS, Ionna F, Longo F, Aversa C, Botti G,
et al. Sclerosing polycyst adenosis of the parotid gland: report
of  one case diagnosed by ﬁne-needle cytology with in situ
malignant transformation. Diagn Cytopathol. 2010;38:
368–73.
